Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja Beck-Popovic

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
BMC Pediatrics|February 18, 2018
Patterns of paediatric end-of-life care: a chart review across different care settings in SwitzerlandKarin Zimmermann, Eva Cignacco, Sandra Engberg, et al.
Pediatric Blood & Cancer|June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy ForumSteven G DuBois, Lucas Moreno, John Anderson, et al.
JCO Precision Oncology|July 1, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN StudyHannah E Hartley, Fang Chyi Fong, Alem S Gabriel, et al.
The British Journal of Ophthalmology|September 16, 2020
Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countriesIdo Didi Fabian, Andrew W Stacey, Allen Foster, et al.
JAMA Oncology|February 28, 2020
Global Retinoblastoma Presentation and Analysis by National Income Level, Ido Didi Fabian, Elhassan Abdallah, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
BMC Pediatrics|February 18, 2018
Patterns of paediatric end-of-life care: a chart review across different care settings in SwitzerlandKarin Zimmermann, Eva Cignacco, Sandra Engberg, et al.
Pediatric Blood & Cancer|June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy ForumSteven G DuBois, Lucas Moreno, John Anderson, et al.
JCO Precision Oncology|July 1, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN StudyHannah E Hartley, Fang Chyi Fong, Alem S Gabriel, et al.
The British Journal of Ophthalmology|September 16, 2020
Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countriesIdo Didi Fabian, Andrew W Stacey, Allen Foster, et al.
JAMA Oncology|February 28, 2020
Global Retinoblastoma Presentation and Analysis by National Income Level, Ido Didi Fabian, Elhassan Abdallah, et al.
Pageof 10